Eptifibatide-induced acute profound thrombocytopenia: A case report

Eptifibatide is an antiplatelet agent used in the medical management of acute coronary syndrome. Although multiple studies did not reveal a significant association between eptifibatide and the development of thrombocytopenia, recent case reports brought attention to this relatively rare side effect....

Descripción completa

Detalles Bibliográficos
Autores principales: Alamin, Mohammed A., Al-Mashdali, Abdulrahman, Al Kindi, Dawoud I., Elshaikh, Elkhansa A., Othman, Fahmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592370/
https://www.ncbi.nlm.nih.gov/pubmed/36281191
http://dx.doi.org/10.1097/MD.0000000000028243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592370/
https://www.ncbi.nlm.nih.gov/pubmed/36281191
http://dx.doi.org/10.1097/MD.0000000000028243

Ejemplares similares